GlobalData on MSN21h
Sellas reports Phase IIa trial data of SLS009 for DLBCL treatment
Sellas Life Sciences has reported the multicentre Phase IIa trial data of a highly selective cyclin-dependent kinase 9 (CDK9) ...
The Pharma Letter21h
NICE recommends Breyanzi for B-cell lymphomas
UK health technology assessor the National Institute for Health and Care Excellence (NICE) has issued Final Draft Guidance ...
CAR-TCR Summit Coverage – Track Latest Insights on Novel CAR-T Cell Therapies for B-Cell Malignancies | DelveInsight
A case study on how DelveInsight supported a client with a focused CAR-TCR Summit coverage plan to gain exclusive insights into CAR-T therapies for B-cell malignancies.New York, USA, Feb. 21, 2025 (GL ...
The Irish connection to Banksy’s Crude Oil (Vettriano), now expected to fetch as much as €6m at auction
Image of the week this week comes courtesy of Banksy, whose painting Crude Oil (Vettriano) is set to go to auction at Sotheby’s in London early next month, having been put on the block by the man who ...
FiercePharma21h
Fierce Pharma Asia—Novo Nordisk's fraud accusation; AstraZeneca's China deal; Ono's FDA nod
Novo Nordisk alleges Singaporean biotech KBP Biosciences made misleading statements before the two firms inked a licensing ...
Researchers investigate rare side effect of blood cancer immunotherapy
Researchers have discovered and analyzed a rare but serious side effect of an innovative form of blood cancer therapy. The ...